By enhancing the secretion of insulin in response to elevated blood glucose levels, delaying gastric emptying, and reducing glucagon secretion, Semaglutide effectively lowers blood sugar levels in patients with type 2 diabetes
If you are taking Ozempic, consult your doctor to determine if you should, or need to, stop
Tailoring Your Treatment: Factors Influencing Dosage Decisions Tailoring your semaglutide treatment to fit your needs involves a comprehensive assessment of various factors influencing dosage decisions
Mazieres B, Masquelier AM, Capron MH
PBS Key take-aways Step-before-GLP-1 PBS now demands that an SGLT2-i be trialled (unless contraindicated) and either: caused intolerance, or failed to achieve 0.5 % (5 mmol/mol) HbA1c reduction after 6 months
NICE guideline NG28 recommends GLP-1 receptor agonists for adults with type 2 diabetes who have a BMI of 35 kg/m or higher (adjusted for ethnicity) and specific psychological or medical problems associated with obesity, or a BMI lower than 35 kg/m where insulin therapy would have significant occupational implications or weight loss would benefit other significant obesity-related comorbidities